Envarsus: payments to doctors
Payments that named Envarsus as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.7M
- Providers
- 2,269
- Transactions
- 8,608
- Average per transaction
- $319
The per-transaction average — $319 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,269 providers the average total is $1,209, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $2,743,589 | 100.0% |